Cutler Group LP Actinium Pharmaceuticals, Inc. Put Options Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
Put Options
2 transactions
Others Institutions Holding ATNM
# of Institutions
76Shares Held
7.05MCall Options Held
96.6KPut Options Held
70.5K-
Black Rock Inc. New York, NY1.88MShares$3.41 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.48MShares$2.69 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA666KShares$1.21 Million0.0% of portfolio
-
State Street Corp Boston, MA610KShares$1.11 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0256KShares$465,9670.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $45.8M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...